| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 传染病检测(元) | 379,346,463.02 | 1,042,046,491.96 | 481,064,872.57 | 951,608,292.69 | 427,612,466.40 |
| 毒品(滥用药物)检测(元) | 144,936,256.55 | 286,462,028.18 | - | 330,740,691.47 | 163,593,384.09 |
| 慢性疾病检测(元) | 563,337,286.94 | 1,368,813,985.77 | 761,928,173.27 | 1,118,523,310.41 | 717,820,258.14 |
| 妊娠及优生优育检测(元) | 138,221,708.37 | 293,529,006.27 | - | 266,923,996.95 | - |
| 其他类(元) | - | 73,957,884.48 | - | 97,117,865.88 | - |
| 营业成本(元) | |||||
| 传染病检测(元) | 152,755,061.98 | 436,641,925.49 | 193,633,396.15 | 402,076,175.80 | 175,667,818.15 |
| 毒品(滥用药物)检测(元) | 64,124,690.86 | - | - | 141,537,450.94 | 69,733,584.44 |
| 慢性疾病检测(元) | 152,868,264.22 | 330,183,243.64 | 191,515,944.48 | 276,156,377.53 | 190,571,335.48 |
| 妊娠及优生优育检测(元) | 77,477,072.88 | - | - | - | - |
| 其他类(元) | - | - | - | - | - |
| 毛利(元) | |||||
| 传染病检测(元) | 226,591,401.04 | 605,404,566.47 | 287,431,476.42 | 549,532,116.89 | 251,944,648.25 |
| 毒品(滥用药物)检测(元) | 80,811,565.69 | - | - | 189,203,240.53 | 93,859,799.65 |
| 慢性疾病检测(元) | 410,469,022.72 | 1,038,630,742.13 | 570,412,228.79 | 842,366,932.88 | 527,248,922.66 |
| 妊娠及优生优育检测(元) | 60,744,635.49 | - | - | - | - |
| 其他类(元) | - | - | - | - | - |
| 毛利率(%) | |||||
| 传染病检测(%) | 59.73 | 58.10 | 59.75 | 57.75 | 58.92 |
| 毒品(滥用药物)检测(%) | 55.76 | - | - | 57.21 | 57.37 |
| 慢性疾病检测(%) | 72.86 | 75.88 | 74.86 | 75.31 | 73.45 |
| 妊娠及优生优育检测(%) | 43.95 | - | - | - | - |
| 其他类(%) | - | - | - | - | - |
| 收入构成(%) | |||||
| 传染病检测(%) | 30.95 | 34.00 | 38.70 | 34.42 | 32.67 |
| 毒品(滥用药物)检测(%) | 11.82 | 9.35 | - | 11.96 | 12.50 |
| 慢性疾病检测(%) | 45.96 | 44.66 | 61.30 | 40.45 | 54.84 |
| 妊娠及优生优育检测(%) | 11.28 | 9.58 | - | 9.65 | - |
| 其他类(%) | - | 2.41 | - | 3.51 | - |
| 毛利构成(%) | |||||
| 传染病检测(%) | 29.10 | 36.82 | 33.51 | 34.76 | 28.86 |
| 毒品(滥用药物)检测(%) | 10.38 | 0.00 | - | 11.97 | 10.75 |
| 慢性疾病检测(%) | 52.72 | 63.18 | 66.49 | 53.28 | 60.39 |
| 妊娠及优生优育检测(%) | 7.80 | 0.00 | - | 0.00 | - |
| 其他类(%) | - | 0.00 | - | 0.00 | - |